# Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

> **NCT02671864** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 7200 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** 1: incretin-based therapy
- **OTHER:** 2: other antidiabetic

## Key facts

- **NCT ID:** NCT02671864
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04-11
- **Primary completion:** 2022-04-11
- **Final completion:** 2025-04-11
- **Target enrollment:** 7200 (ESTIMATED)
- **Last updated:** 2023-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02671864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02671864, "Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02671864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*